Watch CBS News

COVID-19 Vaccine

cbsn-fusion-fda-authorizes-covid-vaccine-booster-shots-for-kids-as-millions-return-to-school-thumbnail-866471-640x360.jpg

Pfizer's COVID-19 booster authorized for kids as young as 12

Millions of Americans as young as 12 could soon be able to get a booster shot of a COVID-19 vaccine after the FDA authorized third doses of Pfizer-BioNTech's shot for that age group. CBS News correspondent Meg Oliver reports on the latest step by the agency. Then, Dr. Mati Hlatshwayo Davis, an infectious disease physician at John Cochran VA Medical Center and the Director of Health for the city of St. Louis, joins Nancy Cordes on CBSN with her analysis.

  • Jan 3, 2022
  • 11:45
cbsn-fusion-fda-authorizes-pfizer-covid-vaccine-booster-kids-12-to-15-thumbnail-866289-640x360.jpg

FDA expands access to Pfizer booster

The FDA authorized Pfizer's COVID-19 vaccine booster shot for children between the ages of 12 and 15. The CDC is expected to rule on the decision later this week. It comes as Omicron cases surge nationwide and millions of kids return to school following the holidays. CBS News' Wendy Gillette reports, and then Professor Jodie Guest, vice chair of the Department of Epidemiology at the Rollins School of Public Health at Emory University, joins CBSN to discuss the latest in the fight against COVID-19.

  • Jan 3, 2022
  • 07:00
cbsn-fusion-us-world-continue-to-break-new-daily-covid-19-infection-records-thumbnail-865197-640x360.jpg

U.S., world continue to break daily COVID-19 infection records

The omicron variant is tightening its grip on the U.S. and the world, spreading like wildfire and driving case numbers higher than we've ever seen them before. Nikki Batiste reports on the impact this new variant is having. And then Bradley Blackburn spoke with Dr. Bob Lahita on CBSN about when we could see the amount of cases go down, and Dr. Anthony's comments on why the government isn't changing the definition of "fully vaccinated" to include a COVID-19 booster.

  • Dec 31, 2021
  • 08:40
cbsn-fusion-studies-omicron-variant-less-likely-to-cause-hospitalizations-fda-approves-new-antiviral-pill-thumbnail-861938-640x360.jpg

Scientists learn more about risk from Omicron

New studies out of South Africa and the U.K. suggest the Omicron variant is less likely to cause hospitalizations -- but it can still be deadly. The FDA also authorized a new antiviral pill to treat COVID-19. CBS News' Nancy Chen reports on the latest, and then Dr. Amesh Adalja, an infectious disease expert at Johns Hopkins University Bloomberg School of Public Health, spoke with Jessi Mitchell on CBSN about the Omicron research and how some patients are experiencing different symptoms than earlier strains.

  • Dec 23, 2021
  • 08:24
cbsn-fusion-fda-authorizes-pfizer-pill-to-treat-covid-19-as-omicron-hits-all-50-sates-thumbnail-861641-640x360.jpg

FDA authorizes Pfizer pill to treat COVID

The Food and Drug Administration announced Wednesday it has authorized Pfizer's antiviral pill to treat COVID-19 as the new Omicron variant hits all 50 U.S. states. CBS News correspondent Nancy Chen reports on how the new strain is causing disruptions across the country. Then, CBS News correspondent Mark Strassman has the latest on Omicron's impact on travel as tens of millions of Americans hit the road for the holidays. And lastly, Dr. Elizabeth Clayborne, an adjunct assistant professor of emergency medicine at the University of Maryland School of Medicine, joins Elise Preston on CBSN to break down the day's headlines.

  • Dec 22, 2021
  • 11:46
Show More
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.